{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/NSRX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T11:08:14.852Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":11755,"canonical_name":"Nasus Pharma Ltd","cik":"0002029039","uei":null,"lei":null,"duns":null,"ticker":"NSRX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":16},"count":16,"timeline":[{"ts":"2026-10-08","kind":"sec.filing","form_type":"6-K","title":"6-K — Nasus Pharma Ltd — 2026-10-08","url_slug":"/sec/cik-0002029039/6-k/0001493152-26-046340","accession_number":"0001493152-26-046340","importance":30},{"ts":"2026-09-18","kind":"sec.filing","form_type":"424B5","title":"424B5 — Nasus Pharma Ltd — 2026-09-18","url_slug":"/sec/cik-0002029039/424b5/0001493152-26-043370","accession_number":"0001493152-26-043370","importance":30},{"ts":"2026-09-18","kind":"sec.filing","form_type":"6-K","title":"6-K — Nasus Pharma Ltd — 2026-09-18","url_slug":"/sec/cik-0002029039/6-k/0001493152-26-043342","accession_number":"0001493152-26-043342","importance":30},{"ts":"2026-09-14","kind":"sec.filing","form_type":"6-K","title":"6-K — Nasus Pharma Ltd — 2026-09-14","url_slug":"/sec/cik-0002029039/6-k/0001493152-26-042488","accession_number":"0001493152-26-042488","importance":30},{"ts":"2026-09-11","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Nasus Pharma Ltd — 2026-09-11","url_slug":"/sec/cik-0002029039/effect/9999999995-26-002954","accession_number":"9999999995-26-002954","importance":30},{"ts":"2026-09-04","kind":"sec.filing","form_type":"6-K","title":"6-K — Nasus Pharma Ltd — 2026-09-04","url_slug":"/sec/cik-0002029039/6-k/0001493152-26-041534","accession_number":"0001493152-26-041534","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"F-3","title":"F-3 — Nasus Pharma Ltd — 2026-09-01","url_slug":"/sec/cik-0002029039/f-3/0001493152-26-041040","accession_number":"0001493152-26-041040","importance":30},{"ts":"2026-08-20","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Nasus Pharma Ltd — 2026-08-20","url_slug":"/sec/cik-0002029039/effect/9999999995-26-002715","accession_number":"9999999995-26-002715","importance":30},{"ts":"2026-08-19","kind":"sec.filing","form_type":"6-K","title":"6-K — Nasus Pharma Ltd — 2026-08-19","url_slug":"/sec/cik-0002029039/6-k/0001493152-26-039148","accession_number":"0001493152-26-039148","importance":30},{"ts":"2026-08-19","kind":"sec.filing","form_type":"POS AM","title":"POS AM — Nasus Pharma Ltd — 2026-08-19","url_slug":"/sec/cik-0002029039/pos-am/0001493152-26-039052","accession_number":"0001493152-26-039052","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"6-K","title":"6-K — Nasus Pharma Ltd — 2026-08-17","url_slug":"/sec/cik-0002029039/6-k/0001493152-26-038651","accession_number":"0001493152-26-038651","importance":30},{"ts":"2026-07-29","kind":"sec.filing","form_type":"4","title":"4 — Nasus Pharma Ltd — 2026-07-29","url_slug":"/sec/cik-0002029039/4/0001493152-26-035218","accession_number":"0001493152-26-035218","importance":30},{"ts":"2026-07-28","kind":"sec.filing","form_type":"6-K","title":"6-K — Nasus Pharma Ltd — 2026-07-28","url_slug":"/sec/cik-0002029039/6-k/0001493152-26-034938","accession_number":"0001493152-26-034938","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — Nasus Pharma Ltd — 2026-06-22","url_slug":"/sec/cik-0002029039/4/0001493152-26-029484","accession_number":"0001493152-26-029484","importance":30},{"ts":"2026-06-17","kind":"sec.insider.p","reporter":"Teleman Dan Benjamin","title":"Chief Executive Officer","shares":6550,"price_per_share":3.1,"usd_value":20305,"security_title":"Ordinary Shares","importance":50.020305},{"ts":"2026-06-09","kind":"sec.filing","form_type":"6-K","title":"6-K — Nasus Pharma Ltd — 2026-06-09","url_slug":"/sec/cik-0002029039/6-k/0001493152-26-027929","accession_number":"0001493152-26-027929","importance":30}]}